Alliance Cancer Specialists

What Alliance Cancer Specialists does

Alliance Cancer Specialists, PC is a physician-owned community oncology and hematology medical practice founded in 1984 and headquartered in Bensalem, Pennsylvania. Itself-described as the largest community oncology and hematology practice group in Southeastern Pennsylvania, it operates nine outpatient office locations across the Delaware Valley and Greater Philadelphia region (Bucks, Delaware, Montgomery, and Philadelphia counties) and maintains admitting privileges at eight regional hospital systems including Holy Redeemer, St. Mary, Doylestown, Riddle, Lankenau, Grand View, and Taylor. The practice serves patients diagnosed with solid tumors, hematologic malignancies, and benign blood disorders through three core clinical lines: medical oncology (chemotherapy, immunotherapy, targeted therapy), hematology (diagnostic and therapeutic services for blood disorders), and a community-based clinical trials programme operated in partnership with Sarah Cannon Research Institute and US Oncology Research. Alliance also functions as a Penn Cancer Network Affiliate Practice, integrating referral pathways into the broader Penn Medicine system.

Revenue is generated through fee-for-service medical services billed to patients and insurance carriers, supplemented by clinical trial sponsor funding and patient cost-sharing arrangements. Patient engagement is supported through three EHR portals (NavigatingCare, CareSpace, and Noona) and an online billing platform (G4 Studio Cloud). Go-to-market is sales-led and referral-driven, anchored by primary-care and specialist physician referral networks, patient self-referrals, hospital affiliations, and a portfolio of community partnerships (e.g., National Ovarian Cancer Coalition, American Cancer Society). In April 2026 the practice entered exclusive strategic partnerships with IDEOlogy Health to elevate physician and Advanced Practice Provider education in oncology care, signaling continued investment in clinical infrastructure rather than technology-led differentiation. The practice is privately held, with no disclosed funding rounds, parent company, or institutional ownership; competitive positioning is built on regional scale, credentialed clinical talent (board-certified physicians and ONS-certified specialty nurses), and deep network affiliations rather than proprietary technology.

Name

Alliance Cancer Specialists

Legal name

Alliance Cancer Specialists, PC

Website

https://alliancecancer.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

101–250 employees

Short description

Alliance Cancer Specialists is a physician-owned community oncology and hematology practice — the largest in Southeastern Pennsylvania — operating nine outpatient locations across the Delaware Valley, delivering chemotherapy, immunotherapy, hematology, and clinical trial services to cancer and blood disorder patients.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Care Services

NAICS

Offices of Physicians (62111), Other Outpatient Care Centers (62149), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Medical oncology services
• Hematology treatment
• Cancer care practice
• Clinical trials research
• Community oncology

Headquarters

HQ city

Bensalem

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from providing oncology and hematology medical services billed to patients and insurance providers. Services include consultations, chemotherapy administration, immunotherapy, targeted therapy, and supportive care delivered at office locations and affiliated hospitals.
2. Clinical Trial Services: Revenue from conducting clinical trials through Sarah Cannon Research Institute, including drug administration, monitoring, and data collection services, with potential sponsor funding and cost-sharing arrangements with patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Alliance Cancer Specialists is the largest community oncology and hematology practice group in Southeastern Pennsylvania, delivering diagnosis and treatment for cancer and blood disorders. Core services include medical oncology (chemotherapy, immunotherapy, targeted therapy), hematology evaluation and treatment, clinical trials through the Sarah Cannon Research Institute partnership, and 24/7 on-call physician support for symptom management. Care is delivered across nine outpatient office locations and affiliated hospitals throughout the Delaware Valley and Greater Philadelphia region.

Product overview

Alliance Cancer Specialists operates as a multi-service oncology and hematology practice, the largest community oncology group in Southeastern Pennsylvania. The core clinical offerings consist of Medical Oncology (chemotherapy, immunotherapy, targeted therapy), Hematology (blood disorder diagnosis and treatment), and Clinical Trials conducted through a partnership with Sarah Cannon Research Institute. Patient-facing digital services include three distinct online portals—NavigatingCare, CareSpace, and Noona (for Radiation Oncology)—enabling electronic access to medical records, lab results, and appointment scheduling. Educational resources encompass a Drug Dictionary with links to NCI clinical trials, symptom management guidance with 24/7 on-call physician support, and connections to support groups including American Cancer Society programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology Comprehensive cancer treatment including chemotherapy, immunotherapy, and targeted therapy delivered by board-certified oncologists and ONS-certified specialty nurses in outpatient infusion centers. For patients with solid tumors and hematologic malignancies.
• Hematology Evaluation and treatment for benign and malignant blood disorders including red blood cell, white blood cell, platelet, bone marrow, lymph node, and spleen conditions, bleeding/clotting abnormalities, and immune deficiencies. Includes outpatient bone marrow biopsies, iron infusions, blood transfusions, and therapeutic phlebotomy.
• Clinical Trials & Research Clinical trials program operated in partnership with Sarah Cannon Research Institute, providing access to Phase I-IV trials across multiple cancer types including breast, gynecological, head and neck, leukemia, liver, lung, pancreatic, prostate, and solid tumor malignancies.
• Symptom Management & 24/7 On-Call Support 24/7 physician on-call service and guidance for managing chemotherapy side effects including nausea, vomiting, diarrhea, fever, pain control, and dehydration, helping patients avoid unnecessary emergency room visits.

Quantifiable outcome

• Majority of new FDA-approved cancer therapies have been contributed through Sarah Cannon Research Institute clinical trials

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

Partnerships

Four partnerships are on record, tiered core.

• IDEOlogy HealthcoreStrategic or Co-development Partner · 27 April 2026Two exclusive strategic partnership agreements between Alliance Cancer Specialists and IDEOlogy Health aimed at elevating physician and Advanced Practice Provider education in oncology care. The collaboration combines IDEOlogy Health's multi-channel educational platforms with Alliance's clinical expertise to accelerate the translation of emerging cancer research into routine clinical practice. Designed to improve patient outcomes across the Greater Philadelphia and Delaware Valley region.
• Sarah Cannon Research Institute (SCRI)coreStrategic or Co-development PartnerAlliance Cancer Specialists offers clinical trials through Sarah Cannon Research Institute, one of the world's leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The research program, SCRI at Alliance Cancer Specialists, provides access to the latest clinical trial options as part of an expansive research network.
• Penn Cancer NetworkcoreChannel Partner/ Reseller/ DistributorAlliance Cancer Specialists is a Penn Cancer Network Affiliate Practice Member, enabling referral pathways and integration with the broader Penn Medicine health system for specialized cancer care services.
• US Oncology ResearchcoreStrategic or Co-development PartnerThrough US Oncology Research, one of the largest community-based oncology research programs in the US, Alliance Cancer Specialists provides patients access to the latest advancements in cancer treatment including clinical trials.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Regional players

• Virtua Health Cancer Program: Community-hospital-based oncology program serving southern New Jersey, adjacent to ACS's Pennsylvania footprint. Comparable in scale and community positioning, providing a benchmark for cross-river expansion or referral dynamics.

Direct peers

• Sarah Cannon Research Institute: One of the world's leading community-based oncology research organizations, operating the clinical trials program that ACS leverages. Operates its own cancer centers and physician practice networks, making it both a critical partner and a structural peer for clinical-trial-enabled oncology services.
• Carolinas Oncology Specialty Practices: Multi-site community oncology and hematology practice in the Carolinas, offering similar medical oncology, hematology, infusion, and clinical trial services. Highly comparable business model and scale to ACS for valuation and operating benchmarking purposes.
• Tennessee Oncology: One of the largest community-based oncology practices in the US, operating multiple locations across Tennessee and northern Georgia. Highly comparable multi-site community oncology model with similar services (medical oncology, hematology, clinical trials via Sarah Cannon), and a benchmark community-oncology platform for ACS.

Broad incumbents

• Fox Chase Cancer Center: NCI-designated comprehensive cancer center in Philadelphia, part of Temple University Health System. Competes for the same regional oncology patient population, particularly for hematologic malignancies and clinical trial enrollment.
• US Oncology Network (McKesson): The largest network of community oncology practices in the US, with ~600+ sites. Already a partner of ACS via US Oncology Research for clinical trial access, but operates as a competitor at the platform/network level for physician practice affiliations and PE-backed oncology consolidation.
• OneOncology: National platform for community oncology practices providing shared services, payer contracting, and clinical research infrastructure. A direct platform-level competitor for physician practice affiliations and a potential acquirer/partner for community oncology groups like ACS.
• Main Line Health Cancer Care: Hospital-system-affiliated oncology program operating across Philadelphia's Main Line suburbs. Competes directly for oncology referrals in the same geographic footprint as ACS's Wynnewood, Media, and other Delaware Valley locations.
• Penn Medicine Abramson Cancer Center: The NCI-designated academic cancer center that ACS is affiliated with via Penn Cancer Network. Operates comprehensive inpatient and outpatient oncology services in Philadelphia and competes for the same patient pool, particularly for complex and clinical-trial cases.
• Jefferson Health Sidney Kimmel Cancer Center: NCI-designated cancer center based in Philadelphia with multiple outpatient sites across SE Pennsylvania. Directly competes for community oncology referrals and patients in Bucks, Delaware, and Montgomery counties where ACS operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/pages/category/Oncologist/Alliance-Cancer-Specialists-446374922073420
• LinkedInlinkedin.com/company/alliance-cancer-specialists-pc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alliance Cancer Specialists